Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis Extract as Anaesthetic Premedication
NCT02283281Phase 3Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- May 2015
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nabiximols in postoperative pain, postoperative nausea and vomiting (PONV), anxiety disorder, sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
nabiximols
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)anxiety disorder
Beyond the preview
Go deeper on NCT02283281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02283281.